25 June 2008
Sygnature sponsors Compound Libraries 2008
Sygnature is sponsoring this years Compound Library meeting in Düsseldorf, Germany, 6th-8th October 2008. CEO, Dr Simon Hirst will be presenting Sygnature's approach to Hit-to-lead chemistry under the expanded remit of the conference which now covers library design and Hit-to-lead optimization.
14 April 2008
Sygnature begins £1m expansion of facilities
Sygnature announced today that it has commenced work on a new research facility at BioCity Nottingham, UK. The £1m expansion is the start of a two phase project to create two new state-of-the-art chemistry laboratories to house medicinal chemistry teams. The facility, due to complete in August 2008 will be accompanied by further growth of the medicinal chemistry group.
11 January 2008
RespiVert selects Sygnature for Discovery Collaboration
Today Sygnature announced that RespiVert Limited has selected Sygnature Chemical Services Ltd to support two new discovery collaborations. Under the agreement Sygnature will provide medicinal chemistry resources to the programs aimed at identifying novel approaches to respiratory diseases.
19 October 2007
Sygnature and Chroma Therapeutics success
Sygnature CEO, Simon Hirst has announced the successful completion of another hit-to-lead program, this time with biotechnology company, Chroma Therapeutics Ltd.
14 September 2007
Sygnature strengthens Medicinal Chemistry
Sygnature has announced that Dr David Adams, formerly Head of Chemistry at Neuro3D, and Director of Medicinal Chemistry at Vernalis, has joined the medicinal chemistry team at Sygnature.